Paul Rennart (Sugar Cone Biotech) $CLLS $JUNO $BLUE $NVS
In Biotech, Everyone’s Going Public. What’s Your Excuse?
Alex Lash (Xconomy)
These Superhumans Are Real and Their DNA Could Be Worth Billions
Caroline Chen (Bloomberg BusinessWeek)
Promising Alzheimer's Drugs Disappoint With Incremental Data
Matthew Herper (Forbes) $BIIB $LLY
The Black World of Insys Therapeutics
Roddy Boyd (SIRF) $INSY
The Who’s Who in Next-Generation AAV Vector Technology
Zack Fink (BioTerp Partners)